Compare Stocks → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:MOTSNASDAQ:NVIVNASDAQ:NXGLNASDAQ:STSS Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMOTSMotus GI$0.07-12.5%$0.52$0.07▼$23.40$380K1.31306,078 shs59,675 shsNVIVInVivo Therapeutics$0.58$0.22▼$2.40$997K0.658.25 million shs1.89 million shsNXGLNEXGEL$2.18+0.5%$2.43$1.40▼$3.14$13.51M0.6819,149 shs10,190 shsSTSSSharps Technology$0.29+3.6%$0.33$0.27▼$1.58$4.48M1.04123,093 shs20,356 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMOTSMotus GI-7.65%-59.65%-85.44%-93.36%-99.46%NVIVInVivo Therapeutics0.00%0.00%0.00%-50.67%-75.70%NXGLNEXGEL+0.46%0.00%-17.74%-5.22%+38.69%STSSSharps Technology+1.82%-8.77%-0.48%-5.30%-75.06%SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMOTSMotus GI1.7745 of 5 stars3.55.00.00.00.60.00.6NVIVInVivo TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ANXGLNEXGEL0.1601 of 5 stars0.03.00.00.00.03.30.0STSSSharps Technology0.4971 of 5 stars0.03.00.00.01.82.50.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMOTSMotus GI3.00Buy$28.8841,150.00% UpsideNVIVInVivo TherapeuticsN/AN/AN/AN/ANXGLNEXGELN/AN/AN/AN/ASTSSSharps Technology3.00BuyN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMOTSMotus GI$320K1.10N/AN/A$1.74 per share0.04NVIVInVivo TherapeuticsN/AN/AN/AN/A$6.48 per shareN/ANXGLNEXGEL$4.09M3.32N/AN/A$0.90 per share2.42STSSSharps TechnologyN/AN/AN/AN/A$0.52 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMOTSMotus GI-$12.87M-$28.55N/A∞N/A-4,033.54%N/A-110.70%5/8/2024 (Estimated)NVIVInVivo Therapeutics-$10.49MN/A0.00N/AN/AN/A-75.04%-65.01%N/ANXGLNEXGEL-$3.16M-$0.56N/A∞N/A-77.19%-49.49%-30.50%5/20/2024 (Estimated)STSSSharps Technology-$9.84MN/A0.00∞N/AN/A-103.10%-76.46%7/5/2024 (Estimated)Latest NVIV, NXGL, STSS, and MOTS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/29/2024Q4 2023STSSSharps TechnologyN/A-$0.16-$0.16-$0.16N/AN/A3/18/2024Q4 2023MOTSMotus GIN/A-$4.13-$4.13-$3.78N/A$0.06 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMOTSMotus GIN/AN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/AN/ANXGLNEXGELN/AN/AN/AN/AN/ASTSSSharps TechnologyN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMOTSMotus GI0.461.761.69NVIVInVivo TherapeuticsN/A14.3014.30NXGLNEXGEL0.101.981.46STSSSharps TechnologyN/A1.310.85OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMOTSMotus GI20.06%NVIVInVivo Therapeutics13.78%NXGLNEXGEL2.21%STSSSharps Technology17.17%Insider OwnershipCompanyInsider OwnershipMOTSMotus GI1.57%NVIVInVivo Therapeutics2.45%NXGLNEXGEL27.15%STSSSharps Technology14.10%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableMOTSMotus GI155.03 million4.95 millionNot OptionableNVIVInVivo Therapeutics63.11 million3.03 millionNot OptionableNXGLNEXGEL126.23 million4.54 millionNot OptionableSTSSSharps Technology5715.67 million13.46 millionNot OptionableNVIV, NXGL, STSS, and MOTS HeadlinesSourceHeadlineSharp’s new compact soundbar delivers affordable Dolby Atmosmsn.com - April 18 at 10:07 AMSharp launches its first ever dual drawer air fryer, and the price will surprise youyahoo.com - April 16 at 12:25 PMSharp's 55 inch and Aquos's return to the future | Proofthevermilion.com - April 11 at 10:20 AMSharp Now Shipping Digital Production Pressespiworld.com - April 2 at 5:22 PMSonja Sharplatimes.com - March 23 at 3:32 AMShipping lifer Sharp-Patel seeks to inspire the next generation of womentradewindsnews.com - March 22 at 4:53 PMSharp mulls cutting SDP loose, large-sized LCD lines at riskdigitimes.com - March 22 at 6:51 AMEXCLUSIVE: The Review Sits Down with President Richard Sallerstanfordreview.org - March 16 at 8:01 AMSharps Technology signs sales and distribution agreement with Roncadelle Operationsmsn.com - March 7 at 12:09 PMSharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systemsglobenewswire.com - March 7 at 8:00 AMSharp set to unveil color e-paper display solutions in the U.S. in Marchgoodereader.com - February 22 at 9:54 PMSharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombiafinance.yahoo.com - February 21 at 12:59 PMSharps Technology to partner for drug delivery systemsmsn.com - February 19 at 2:24 PMSharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systemsfinance.yahoo.com - February 16 at 6:23 PMSharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systemsglobenewswire.com - February 16 at 2:42 PMMonotype Acquires an Award-Winning Type Collection from Sharp Type's Library and Welcomes Sharp Type as a Creative Partnertmcnet.com - February 7 at 3:51 AMVideo: Top Secret Razor Sharp Tubes with Ben Gravymsn.com - February 5 at 10:34 PMSharps Technology Inc (STSS) may enjoy gains as insiders got busy in the recent daysknoxdaily.com - February 5 at 12:34 PMSharp offers more batt for your buck with zinc-air researchdigitimes.com - February 2 at 10:25 AMSharp Introduces All-New MultiSync® ME Series Product Lineuptmcnet.com - February 1 at 1:46 PMSharp Discusses Joint Venture Developmentscommercialintegrator.com - February 1 at 1:46 PMSharp unveils 580 W TOPCon solar panel with 22.45% efficiencypv-magazine-usa.com - January 31 at 2:51 PMSharp TVs Reviewsconsumeraffairs.com - January 31 at 4:10 AMThe Future Arrives in 2024 Security Led by Hi Sharp's Flagship SVRvaldostadailytimes.com - January 26 at 10:43 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsMotus GINASDAQ:MOTSMotus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. Motus GI Holdings, Inc. was founded in 2008 and is based in Fort Lauderdale, Florida.InVivo TherapeuticsNASDAQ:NVIVInVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. On February 1, 2024, InVivo Therapeutics Holdings Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with InVivo Therapeutics Corporation.NEXGELNASDAQ:NXGLNEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.Sharps TechnologyNASDAQ:STSSSharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.